Conditions and Treatments Conditions acute lymphoblastic leukemia acute myelogenous leukemia (AML) aids-related lymphoma anemia bleeding tendency blood cancer cancer chronic lymphocytic leukemia (CLL) chronic myelogenous leukemia (CML) cutaneous t-cell lymphoma hairy cell leukemia hematologic malignancies leukemia lymphoma multiple myeloma myelodysplastic syndromes (MDS) myeloproliferative disorder platelet disorder preleukemia Treatments bone marrow transplantation (BMT) CAR T cell therapy cell therapy stem cell therapy stem cell transplant Learn more about conditions we treat at NYU Langone: Acute Lymphoblastic Leukemia , Leukemia , Acute Myeloid Leukemia , AIDS-Related Lymphoma , Chronic Lymphocytic Leukemia , Chronic Myelogenous Leukemia , Cutaneous T-Cell Lymphoma , Hairy Cell Leukemia , Myelodysplastic Syndromes , Myeloproliferative Disorders , Non-Hodgkin Lymphoma , Hodgkin Lymphoma , Primary Central Nervous System Lymphoma , Multiple Myeloma Credentials Positions Associate Professor, Department of Medicine at NYU Grossman School of Medicine Director, Transplantation and Cellular Therapy Program Director, Clinical Leukemia Program, Perlmutter Cancer Center Board Certifications American Board of Internal Medicine (Hematology), 2012 American Board of Internal Medicine (Medical Oncology), 2012 Education and Training Fellowship, NYU Grossman School of Medicine, Hematology/Oncology, 2012 Residency, State University of NY at Buffalo, Internal Medicine, 2009 MD from American University of Beirut, 2004 Is this your profile
While the primary endpoint (cerebral glucose metabolism) was not met, these findings suggest injectable GLP-1s may be more effective than oral formulations
Organon, Netherlands)
In contrast, the cis conformation of aberrantly phosphorylated tau (p-tau) has been linked to pathogenesis in neurodegenerative disease and of cognitive symptoms (65, 93, 94)
More physiologically relevant models such as 3D organoids, patient-derived xenografts, and genetically engineered mice are needed to better predict nanoplatform behavior
